NL8002812A - 6,7-secoergolinen. - Google Patents

6,7-secoergolinen. Download PDF

Info

Publication number: NL8002812A
Authority: NL; Netherlands
Prior art keywords: secoergoline; dimethyl; group; methoxy; examples
Prior art date: 1979-09-20

Application number

NL8002812A

Other languages

English (en)

Dutch (nl)

Original Assignee

Erba Farmitalia

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-09-20

Filing date

1980-05-14

Publication date

1981-03-24

1980-05-14 Application filed by Erba Farmitalia filed Critical Erba Farmitalia

1981-03-24 Publication of NL8002812A publication Critical patent/NL8002812A/nl

Links

150000001875 compounds Chemical class 0.000 claims description 24
125000000217 alkyl group Chemical group 0.000 claims description 10
125000004432 carbon atom Chemical group C* 0.000 claims description 9
238000000034 method Methods 0.000 claims description 7
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 5
150000003839 salts Chemical class 0.000 claims description 5
TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 claims description 4
229910052757 nitrogen Inorganic materials 0.000 claims description 4
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 4
238000007142 ring opening reaction Methods 0.000 claims description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 3
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
125000000623 heterocyclic group Chemical group 0.000 claims description 3
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
229910052700 potassium Inorganic materials 0.000 claims description 3
238000002360 preparation method Methods 0.000 claims description 3
239000012312 sodium hydride Substances 0.000 claims description 3
229910000104 sodium hydride Inorganic materials 0.000 claims description 3
AWFDCTXCTHGORH-HGHGUNKESA-N 6-[4-[(6ar,9r,10ar)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-carbonyl]piperazin-1-yl]-1-methylpyridin-2-one Chemical group O=C([C@H]1CN([C@H]2[C@@H](C=3C=CC=C4NC(Br)=C(C=34)C2)C1)C)N(CC1)CCN1C1=CC=CC(=O)N1C AWFDCTXCTHGORH-HGHGUNKESA-N 0.000 claims description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
125000003545 alkoxy group Chemical group 0.000 claims description 2
125000003277 amino group Chemical group 0.000 claims description 2
239000003054 catalyst Substances 0.000 claims description 2
239000003085 diluting agent Substances 0.000 claims description 2
238000005984 hydrogenation reaction Methods 0.000 claims description 2
125000004356 hydroxy functional group Chemical group O* 0.000 claims description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 claims description 2
ANYSGBYRTLOUPO-UHFFFAOYSA-N lithium tetramethylpiperidide Chemical compound [Li]N1C(C)(C)CCCC1(C)C ANYSGBYRTLOUPO-UHFFFAOYSA-N 0.000 claims description 2
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
239000008194 pharmaceutical composition Substances 0.000 claims description 2
229910052697 platinum Inorganic materials 0.000 claims description 2
239000011591 potassium Substances 0.000 claims description 2
ZMJJCODMIXQWCQ-UHFFFAOYSA-N potassium;di(propan-2-yl)azanide Chemical compound [K+].CC(C)[N-]C(C)C ZMJJCODMIXQWCQ-UHFFFAOYSA-N 0.000 claims description 2
125000003373 pyrazinyl group Chemical group 0.000 claims description 2
125000002098 pyridazinyl group Chemical group 0.000 claims description 2
125000004076 pyridyl group Chemical group 0.000 claims description 2
125000000714 pyrimidinyl group Chemical group 0.000 claims description 2
229910052708 sodium Inorganic materials 0.000 claims description 2
239000011734 sodium Substances 0.000 claims description 2
239000002904 solvent Substances 0.000 claims description 2
125000000335 thiazolyl group Chemical group 0.000 claims description 2
238000009903 catalytic hydrogenation reaction Methods 0.000 claims 1
230000008018 melting Effects 0.000 description 7
238000002844 melting Methods 0.000 description 7
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
239000006260 foam Substances 0.000 description 5
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
239000002253 acid Substances 0.000 description 3
238000001704 evaporation Methods 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
239000000725 suspension Substances 0.000 description 2
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
-1 6-methyl-3 -methoxycarbonyl-10a-methoxyergoline Chemical compound 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
101100167062 Caenorhabditis elegans chch-3 gene Proteins 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
208000001953 Hypotension Diseases 0.000 description 1
RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
239000002160 alpha blocker Substances 0.000 description 1
239000002269 analeptic agent Substances 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
239000000010 aprotic solvent Substances 0.000 description 1
125000003180 beta-lactone group Chemical group 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
229940125773 compound 10 Drugs 0.000 description 1
229940125846 compound 25 Drugs 0.000 description 1
229940125898 compound 5 Drugs 0.000 description 1
125000004093 cyano group Chemical group *C#N 0.000 description 1
229960004704 dihydroergotamine Drugs 0.000 description 1
HESHRHUZIWVEAJ-JGRZULCMSA-N dihydroergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2[C@@H](C3=CC=CC4=NC=C([C]34)C2)C1)C)C1=CC=CC=C1 HESHRHUZIWVEAJ-JGRZULCMSA-N 0.000 description 1
230000003291 dopaminomimetic effect Effects 0.000 description 1
239000003480 eluent Substances 0.000 description 1
OWEUDBYTKOYTAD-MKTPKCENSA-N ergocristine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](C(N21)=O)(NC(=O)[C@@H]1C=C2C3=CC=CC4=NC=C([C]34)C[C@H]2N(C)C1)C(C)C)C1=CC=CC=C1 OWEUDBYTKOYTAD-MKTPKCENSA-N 0.000 description 1
HEFIYUQVAZFDEE-UHFFFAOYSA-N ergocristinine Natural products N12C(=O)C(C(C)C)(NC(=O)C3C=C4C=5C=CC=C6NC=C(C=56)CC4N(C)C3)OC2(O)C2CCCN2C(=O)C1CC1=CC=CC=C1 HEFIYUQVAZFDEE-UHFFFAOYSA-N 0.000 description 1
208000021822 hypotensive Diseases 0.000 description 1
230000001077 hypotensive effect Effects 0.000 description 1
INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
231100000053 low toxicity Toxicity 0.000 description 1
OSKZYLPFYNARRX-IIWDCPNDSA-N methyl (6ar,10ar)-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-carboxylate Chemical compound C1=CC([C@H]2CC(CN(C)[C@@H]2C2)C(=O)OC)=C3C2=CNC3=C1 OSKZYLPFYNARRX-IIWDCPNDSA-N 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
239000000203 mixture Substances 0.000 description 1
LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
229910052763 palladium Inorganic materials 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
125000004193 piperazinyl group Chemical group 0.000 description 1
239000003586 protic polar solvent Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000007858 starting material Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

NL8002812A 1979-09-20 1980-05-14 6,7-secoergolinen. NL8002812A (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB7932589		1979-09-20
GB7932589		1979-09-20

Publications (1)

Publication Number	Publication Date
NL8002812A true NL8002812A (nl)	1981-03-24

Family

ID=10507944

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8002812A NL8002812A (nl)	1979-09-20	1980-05-14	6,7-secoergolinen.

Country Status (6)

Country	Link
JP (1)	JPS5646866A (fr)
BE (1)	BE883295A (fr)
DE (1)	DE3018514A1 (fr)
FR (1)	FR2465721A1 (fr)
IT (1)	IT1196913B (fr)
NL (1)	NL8002812A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI76085C (fi) *	1981-07-21	1988-09-09	Erba Farmitalia	Foerfarande foer framstaellning av ergolinderivat.
JPH0737655Y2 (ja) *	1989-02-06	1995-08-30	美津濃株式会社	野球・ソフトボール用プロテクター
JPH08257197A (ja) *	1995-03-06	1996-10-08	Paul Braithwal Brendon	スポーツ選手のための保護手段
CN115894519B (zh) *	2022-10-21	2024-05-17	浙江大学	一种三肽生物碱化合物及其制备方法和应用

1980
- 1980-05-14 BE BE0/200611A patent/BE883295A/fr not_active IP Right Cessation
- 1980-05-14 DE DE19803018514 patent/DE3018514A1/de not_active Withdrawn
- 1980-05-14 NL NL8002812A patent/NL8002812A/nl not_active Application Discontinuation
- 1980-05-15 JP JP6466080A patent/JPS5646866A/ja active Pending
- 1980-05-15 IT IT8022080A patent/IT1196913B/it active
- 1980-05-16 FR FR8011003A patent/FR2465721A1/fr not_active Withdrawn

Also Published As

Publication number	Publication date
DE3018514A1 (de)	1981-04-09
IT1196913B (it)	1988-11-25
IT8022080A0 (it)	1980-05-15
JPS5646866A (en)	1981-04-28
BE883295A (fr)	1980-09-01
FR2465721A1 (fr)	1981-03-27

Legal Events

Date	Code	Title	Description
1983-01-03	BV	The patent application has lapsed

Publication	Publication Date	Title
CS259894B2 (en)	1988-11-15	Method of substituted nicotinates preparation
EP0286263B1 (fr)	1991-05-15	Imides polycycliques ayant une activité psychotropique
AU699120B2 (en)	1998-11-19	Azacycloalcane derivatives, their preparation and their applications in therapy
Yadav et al.	2017	Synthesis of β-carboline-fused 1, 4-oxazepines and their assessment as antiplasmodial agents
NL8002812A (nl)	1981-03-24	6,7-secoergolinen.
WO2023122600A1 (fr)	2023-06-29	Antagonistes d'un récepteur de glucocorticoïdes à base d'indazole pipérazine
AU606907B2 (en)	1991-02-21	Process for the synthesis of 1-substituted imidazole-5-carboxylic acids and carboxylic acid derivatives
SK16896A3 (en)	1996-10-02	1-£2-(substituted vinyl)\|-3,4-dihydro-5h-2,3-benzodiazepine derivatives
US4507478A (en)	1985-03-26	2-Mercaptopyrimidohexahydroquinolines and related compounds
FR2689509A1 (fr)	1993-10-08	Nouveaux dérivés spiraniques du 3-amino chromane, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
SU509236A3 (ru)	1976-03-30	Способ получени производных5-(31-фенил-11-оксипропил)-6-диалкил-аминоалкокси-4,7-диметокси-2,3-дигидробензофуранов
FI73674B (fi)	1987-07-31	Foerfarande och mellanprodukt foer framstaellning av farmakologiskt vaerdefulla 1-fenylindazol-3-on-foereningar.
Wermann et al.	2005	Novel triazinium-imidothioate zwitterions: intermediates in the reaction of [1, 3, 4] thiadiazolo [2, 3-d][1, 2, 4] triazolo [1, 5-a][1, 3, 5] triazinium cations with amines
US3957785A (en)	1976-05-18	Bβ-Pyrimidino-aminomethyl-10α-ergoline and 10α-methoxyergoline derivatives
McQuaid et al.	1989	Substituted 5-amino-4, 5, 6, 7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity
KR870000234B1 (ko)	1987-02-18	트랜스-dI-5-치환된-7-임의 치환된-4,4a,5,6,7,8,8a,9-옥타하이드로-1H(및 2H)피라졸로[3,4-g] 퀴나졸린의 제조 방법
Obase et al.	1978	Synthesis and adrenergic β-blocking activity of some propanolamine derivatives
CA1108156A (fr)	1981-09-01	Derives du phenanthrene, preparatio et composes pharmaceutiques les contenant
EP1004579A1 (fr)	2000-05-31	Procede pour la preparation des 2,3-dihydroindoles (indolines), certaines 2,3-dihydroindoles et leur utilisation
Yamada et al.	1999	CARBONYLMETHYLENEh2-PIPERAZINONES AND THEIR
US3322778A (en)	1967-05-30	Novel ether derivatives of benzmorphans
CN115433200B (zh)	2023-07-21	含苯并二氢吡喃-4-酮结构的四环化合物、合成方法及应用
Al‐Talib et al.	1988	A convenient synthesis of amino‐substituted 1, 3, 5‐oxadiazinium salts
SU561513A3 (ru)	1977-06-05	Способ получени производных пиперазина или их солей
Gao et al.	2014	A facile synthesis of bisquinoline derivatives via the Williamson reaction